Peter Meijer sold Vertex Pharmaceuticals Inc (NASDAQ: VRTX)
Peter Meijer (R-MI), a U.S. Representative, has disclosed 1 trade in Vertex Pharmaceuticals Inc (VRTX) since 2021, a single sale, worth an estimated $8K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: Peter Meijer sold $1,001 - $15,000 of Vertex Pharmaceuticals Inc (NASDAQ: VRTX) on January 28, 2021. Since that trade, VRTX is up +109.40% against the S&P 500 up +110.98%, an outperformance of -1.58%.
Data updated
Peter Meijer's VRTX trades vs the price
VRTX is up +109.40% since Peter Meijer sold on January 28, 2021, versus +110.98% for the S&P 500.
Performance since this trade
All Peter Meijer VRTX trades
Peter Meijer & VRTX trading FAQ
Is it legal for Peter Meijer to trade Vertex Pharmaceuticals Inc (VRTX) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Vertex Pharmaceuticals Inc (VRTX), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Peter Meijer sell VRTX?
Peter Meijer disclosed a sale of $1,001 - $15,000 of Vertex Pharmaceuticals Inc (VRTX) on January 28, 2021, according to public STOCK Act filings.
How has VRTX performed since Peter Meijer's trade?
Since Peter Meijer sold VRTX on January 28, 2021, the stock is up +109.40%, versus +110.98% for the S&P 500 over the same period, an outperformance of -1.58%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional VRTX trades?
Quantellect tracks every disclosed congressional trade in Vertex Pharmaceuticals Inc (VRTX) on the Vertex Pharmaceuticals Inc congressional trading page, which aggregates filings across all members of Congress.
Peter Meijer's VRTX tradesAll congressional filings for Vertex Pharmaceuticals IncPeter Meijer's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.